Q3 2019 Holdings
Filed 2019-11-14 | 138 holdings | $369.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Acadia Healthcare Company in(ACHC) | COM | 00404A109 | $40.1M | 1,290,000 | 10.8% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $39.8M | 525,000 | 10.8% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $39.5M | 970,000 | 10.7% |
| Coherus Biosciences Inc(CHRS) | COM | 19249H103 | $38.1M | 1,880,000 | 10.3% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $26.6M | 330,500 | 7.2% |
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $26.3M | 214,800 | 7.1% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $20.7M | 181,700 | 5.6% |
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $20.6M | 213,500 | 5.6% |
| Align Technology Inc(ALGN) | COM | 016255101 | $20.1M | 110,900 | 5.4% |
| Collegium Pharmaceutical Inc(COLL) | COM | 19459J104 | $18.1M | 1,577,893 | 4.9% |
| Adaptive Biotechnologies COR(ADPT) | COM | 00650F109 | $16.8M | 545,000 | 4.6% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $14.4M | 3,055,261 | 3.9% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $11.4M | 352,500 | 3.1% |
| Centene Corp del(CNC) | COM | 15135B101 | $9.9M | 229,800 | 2.7% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $9.6M | 142,500 | 2.6% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $6.7M | 187,000 | 1.8% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $3.2M | 150,000 | 0.9% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $3.2M | 2,974,754 | 0.9% |
| Adaptimmune Therapeutics PLC(ADAPY) | SPONDS ADR | 00653A107 | $1.3M | 875,000 | 0.4% |
| Corvus Pharmaceuticals Inc(CRVS) | COM | 221015100 | $1.2M | 400,000 | 0.3% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $128.4K | 591,000 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $111.1K | 1,232,500 | 0.0% |
| Wellcare Health Plans Inc | COM | 94946T106 | $83.1K | 320,500 | 0.0% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $82.3K | 152,500 | 0.0% |
| Amarin Corp PLC | SPONS ADR NEW | 023111206 | $70.5K | 4,650,000 | 0.0% |
| HCA Healthcare Inc(HCA) | COM | 40412C101 | $56.3K | 467,500 | 0.0% |
| Encompass Health Corp(EHC) | COM | 29261A100 | $51.6K | 815,000 | 0.0% |
| Spark Therapeutics Inc | COM | 84652J103 | $49.0K | 505,371 | 0.0% |
| Teleflex Inc(TFX) | COM | 879369106 | $44.2K | 130,000 | 0.0% |
| Pacira Biosciences(PCRX) | COM | 695127100 | $43.8K | 1,150,000 | 0.0% |
| Insulet Corp(PODD) | COM | 45784P101 | $43.0K | 260,500 | 0.0% |
| Irhythm Technologies Inc(IRTC) | COM | 450056106 | $41.1K | 555,000 | 0.0% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $40.4K | 183,500 | 0.0% |
| Medicines Co | COM | 584688105 | $40.0K | 800,000 | 0.0% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $39.0K | 431,750 | 0.0% |
| Stryker Corp(SYK) | COM | 863667101 | $38.7K | 179,000 | 0.0% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $34.4K | 203,000 | 0.0% |
| Baxter Intl Inc(BAX) | COM | 071813109 | $33.7K | 385,000 | 0.0% |
| Radius Health Inc | COM NEW | 750469207 | $33.5K | 1,300,000 | 0.0% |
| Cigna Corp New(CI) | COM | 125523100 | $32.9K | 216,900 | 0.0% |
| Idexx Labs Inc(IDXX) | COM | 45168D104 | $32.7K | 120,200 | 0.0% |
| Penumbra Inc(PEN) | COM | 70975L107 | $32.6K | 242,500 | 0.0% |
| Portola Pharmaceuticals Inc | COM | 737010108 | $28.2K | 1,050,000 | 0.0% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $26.7K | 175,000 | 0.0% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $26.0K | 608,000 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $25.4K | 337,500 | 0.0% |
| Alder Biopharmaceuticals Inc(ALDR1EUR) | COM | 014339105 | $24.5K | 1,300,000 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $24.5K | 333,500 | 0.0% |
| Amgen Inc(AMGN) | COM | 031162100 | $24.4K | 126,000 | 0.0% |
| Thermo Fisher Scientific Inc(TMO) | COM | 883556102 | $23.6K | 81,000 | 0.0% |